DPP-4 inhibitors, which are used as diabetes drugs, block the enzymatic activity of DPP-4, therefore inhibiting degradation of the incretin hormones responsible for stimulating insulin secretion as a means of controlling blood glucose level [62]. The gene discussed is DPP4; the disease is diabetes mellitus.